BDNF in fragile X syndrome.
Neuropharmacology
; 76 Pt C: 729-36, 2014 Jan.
Article
en En
| MEDLINE
| ID: mdl-23727436
Palabras clave
2-methyl-6-(phenylethynyl)pyridine hydrochloride; ADHD; Autism; BDNF; Brain-derived neurotrophic factor; CYFIP1; Circuit function; Differentiation; FMR1 gene; FMR1 protein; FMRP; FMRP-interacting protein; FXS; FXTAS; Fmr1 KO; Fmr1 gene; Fragile X syndrome; GABA; IP; LTD; LTP; MPEP; Mental retardation; N-methyl-d-aspartate receptor; NMDA; NPC; Neural progenitors; RNA interference; RNAi; TrkB receptor; aNPCs; adult neural progenitor cells; attention deficit and/or hyperactive disorder; fragile X mental retardation 1 gene; fragile X mental retardation 1 knockout; gamma-aminobutyric acid; gp1; group 1; intermediate progenitor; long-term depression; long-term potentiation; mGluR; metabotropic glutamate receptor; neural progenitor cells; tremor/ataxia syndrome; tropomyosin-related kinase B receptor
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Factor Neurotrófico Derivado del Encéfalo
/
Síndrome del Cromosoma X Frágil
Tipo de estudio:
Prognostic_studies
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Neuropharmacology
Año:
2014
Tipo del documento:
Article